A US federal appeals court has ruled against the Washington Department of Fish and Wildlife after it failed to properly accommodate employees’ religious objections to COVID-19 vaccination. The case, *Cherry et al.
More
Both Spain and Portugal have published draft legislation to comply with the EU Pay Transparency Directive, despite August traditionally being a quieter period for European lawmaking. The EU Pay Transparency Directive, formally
More
Clio has appointed Pablo Arredondo as senior vice president, judiciary, marking the company’s first dedicated move to extend its technology into the courts. Arredondo cofounded Casetext in 2013 after working as a
More
The legal profession is grappling with a dramatic surge in demand for law school places, reshaping how institutions evaluate prospective students. Ethan Madore, the coordinator of 7Sage’s admissions consulting program, has been
More
UK stocks made modest gains on Tuesday as Bitcoin extended its rally to a more than three-month high, supporting broader investor risk appetite. The FTSE 100 gained 0.15% as of 03:25 ET,
More
Nuclear energy stocks have staged an impressive rally throughout August, with the broader sector climbing 16% and several standout names delivering even stronger returns for investors. The surge reflects growing institutional and
More
A prominent executive search firm operating at the heart of FTSE recruitment has been rescued from administration by a competing rival in the sector. The firm, which specialised in placing senior leaders
More
The Lamborghini Revuelto Miura 60 Homage is a strictly limited special edition celebrating 60 years since the original Miura changed the supercar world. Only 99 examples will be produced, each built through
More
Bausch + Lomb has developed a first-in-class combination eye drop targeting two of the primary underlying causes of dry eye disease simultaneously. The novel treatment combines 5% lifitegrast, the active ingredient in
More
Vikram Anand, president of compliance services at EVERSANA, has set out a vision for where pharmacovigilance infrastructure is headed next. Anand’s remarks close out a series of conversations with Pharmaceutical Commerce focused
More